This is a list of investigational long COVID drugs, or drugs that are currently under development for clinical use for the treatment of post-acute COVID-19 syndrome (long COVID) but are not yet approved.
Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in parentheses. The format of list items is "Name (Synonyms) – Mechanism of Action [Reference]".
This list was last comprehensively updated in September 2025. It is likely to become outdated with time.